Handelsbanken Fonder AB Buys 79,853 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Handelsbanken Fonder AB increased its position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 14.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 627,522 shares of the medical device company's stock after purchasing an additional 79,853 shares during the period. Handelsbanken Fonder AB owned about 0.31% of Cooper Companies worth $57,688,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of COO. Victory Capital Management Inc. increased its position in shares of Cooper Companies by 23.0% during the third quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company's stock valued at $435,856,000 after purchasing an additional 737,726 shares during the period. JPMorgan Chase & Co. grew its position in Cooper Companies by 13.2% in the third quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company's stock valued at $543,979,000 after acquiring an additional 573,908 shares during the period. International Assets Investment Management LLC bought a new stake in Cooper Companies in the third quarter valued at $46,727,000. Swedbank AB grew its position in Cooper Companies by 14.0% in the fourth quarter. Swedbank AB now owns 1,629,602 shares of the medical device company's stock valued at $149,809,000 after acquiring an additional 200,000 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in Cooper Companies by 11.9% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,818,610 shares of the medical device company's stock valued at $200,665,000 after acquiring an additional 194,118 shares during the period. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Stock Down 0.2 %

Shares of NASDAQ:COO traded down $0.21 during mid-day trading on Friday, reaching $88.48. 1,564,854 shares of the stock were exchanged, compared to its average volume of 1,460,937. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The company has a market cap of $17.66 billion, a P/E ratio of 45.37, a P/E/G ratio of 2.19 and a beta of 1.00. The Cooper Companies, Inc. has a one year low of $84.76 and a one year high of $112.38. The stock's 50 day simple moving average is $92.94 and its 200-day simple moving average is $99.55.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.00 by $0.04. The business had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Cooper Companies's quarterly revenue was up 9.8% on a year-over-year basis. During the same period last year, the company earned $0.87 earnings per share. As a group, equities research analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the company. Needham & Company LLC reiterated a "hold" rating on shares of Cooper Companies in a research report on Friday, December 6th. Citigroup decreased their target price on Cooper Companies from $116.00 to $115.00 and set a "buy" rating on the stock in a report on Friday, December 6th. Morgan Stanley cut their price target on Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating on the stock in a research note on Friday, December 6th. Wells Fargo & Company upped their price target on Cooper Companies from $115.00 to $118.00 and gave the company an "overweight" rating in a research note on Friday, December 6th. Finally, StockNews.com lowered Cooper Companies from a "buy" rating to a "hold" rating in a research note on Wednesday, December 11th. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $117.00.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.